Immunic focusing on business development during Q4 : vimarsa

Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive London after the Munich-based biotech company released a...

Related Keywords

Munich , Bayern , Germany , London , City Of , United Kingdom , Daniel Vitt , Thomas Warner , Immunic Inc , Us Patent Office , Proactive London , Progressive Multiple ,